SCHEMBL9637503

SCHEMBL9637503

O=C1NC(=S)NC1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11581949 0.79 ALDH1A1 (0.43)
SCHEMBL6745047 0.77
SCHEMBL21694735 0.77 KDM4E (0.41)
SCHEMBL21694727 0.77 KDM4E (0.41)
SCHEMBL9193586 0.76
SCHEMBL561443 0.76
SCHEMBL8135678 0.75 GDA (0.41)
SCHEMBL1598193 0.74 ALDH1A1 (0.64)
SCHEMBL21694741 0.74 NPSR1 (0.50)
SCHEMBL21694746 0.71 KDM4E (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114099712-A Altering microbial population and improving microbial populations 斯尼普技术有限公司 2022-03-01 CN disclosed
CN-112292145-A Treatment and prevention of microbial infections 斯尼普生物群系有限公司 2021-01-29 CN disclosed
CN-111051510-A Altering microbial populations and modifying microbial populations 斯尼普技术有限公司 2020-04-21 CN disclosed
US-5137904-A Useful in the treatment of atherosclerosis and thrombosis G. D. SEARLE & CO. (US) 1992-08-11 US disclosed
US-5137904-A Useful in the treatment of atherosclerosis and thrombosis G. D. SEARLE & CO. (US) 1992-08-11 US disclosed